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ABSTRACT 
Purpose: The main goal of this study was to search for predictors, of post-operative dysphagia and 
heartburn, need for medical treatment during follow-up and the occurrence on intra and post-operative 
morbidity in patients with achalasia. 
Methods: The records of the patients who underwent myotomy for achalasia from 2005 to 2014 were 
reviewed (n=46).  Data regarding pre-operative and post-operative manometry and pH-metry was 
compiled, along with patients’ symptoms and characteristics.. 
Results: Our sample was composed by 25 female patients and 21 male patients. No parameter of the 
conventional manometry was associated with post-operative dysphagia, heartburn or medical treatment. 
Pre-operative heartburn and regurgitation were associated with less post-operative dysphagia (p<0.01 and 
p=0,034, respectively); Pre-operative dilatations were associated with post-operative morbidity (p=0.035) 
but not with intra-operatory morbidity (p=0.898). Relapse of achalasia was associated with greater usage 
of PPI during follow-up (p= 0.028). 
Conclusions: Heller myotomy is an effective treatment option for Achalasia. Dilatations should be 
used carefully since they can lead to an increase in post—operative morbidity. Patients with relapse of 
achalasia are more likely to need medical treatment after re-intervention while patients with pre-operative 
regurgitation and heartburn have less post-operative dysphagia. 
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INTRODUCTION 
Achalasia is a disorder of oesophageal motility characterized by impaired relaxation of the lower 
oesophageal sphincter (LES), frequently associated with an increase in the pressure of LES and an 
absence of peristalsis of the oesophageal body [1]. Complete lower esophageal sphincter (LES) relaxation 
occurs in approximately 15–30% of patients with achalasia and is not a characteristic of early achalasia 
[2]. It’s annual incidence is about 1 case per 100000 habitants and the prevalence is around 10 in 10000 
[3]. There is no sexual and racial prevalence and, while it is a disease that can appear at any age, there are 
two peaks of incidence: between 20-40 years old and between 70-80 years old [3, 4]. 
The main symptom is dysphagia, usually progressive for solids and liquids, although it can also present 
itself as paradoxal dysphagia. Other common presentation symptoms include thoracic pain, regurgitation, 
heartburn and weight loss [1, 5].  
As of now, the pathogenesis of this disease is unknown, [6] although it is hypothesized that it results from 
the loss of the ganglionic cells of the myenteric plexus of the esophagus [1]. Other current train of thought 
deals with a possible viral etiology [7, 8]. Achalasia has been associated with, at various degrees of risk, 
squamous cell carcinoma. However, there are no recommendations for screening for cancer in patients 
with Achalasia [3, 9].  
Diagnosing Achalasia requires a high index of clinical suspicion. The current gold-standard is the 
oesophageal manometry [6]. A complete workup usually includes oesophageal manometry, upper 
gastrointestinal endoscopy and a barium esophagogram [3]. The cardinal feature of this disease is the 
impaired relaxation of the LES in response to swallowing. Other abnormalities include an increase in the 
LES pressure and absence of peristalsis in the oesophageal body [10].  
Currently, there are two forms of manometry, conventional and the more recent high-resolution 
manometry (HRM). Conventional manometry has some disadvantages in comparison to HRM 
manometry, since it is unable to account for the intrabolus pressure, the crural diaphragm relaxation, 
radial asymmetry of the gastroesophageal junction (GEJ) and deglutive oesophageal shortening [11]. As 
for the upper gastrointestinal endoscopy, it’s important to exclude a serious differential diagnosis, the 
Pseudo-Achalasia [6]. Barium esophagogram can also help in the diagnosis, identifying the so called 
“Bird’s Beak [3, 6]. The advancements brought by HRM allowed the classification of Achalasia into 3 
different subtypes, a classification known as the Chicago Classification of Motility Disorders [12]. Type I 
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represents classic achalasia, associated with low intra-oesophageal pressure  and minimum levels of 
oesophageal contractility; Type II is characterized by panoesophageal pressure elevations and an absence  
of peristalsis [1]; Type III is usually called “spastic achalasia” [5, 10, 13]. HRM proved to be an 
important evolution in terms of diagnosis and classification of Achalasia [14, 15]. 
The available treatments are used for symptom relief. Currently, no curative interventions exist [1]. 
Regarding pharmaceutic interventions, the most common drugs used are calcium channel blockers, but 
they are ineffective [4, 16]. The other treatment options are injection of botulin toxin, pneumatic 
dilatation and surgery. Regarding botulin toxin injection, it’s ineffective in the long term, with its’ effects 
reverting in a period between 6 and 9 months after the intervention [5]. It is currently reserved for elderly 
patients and high surgical risk patients [4]. Pneumatic dilatation and surgical myotomy are more useful 
treatment options. Pneumatic dilatation is performed by insufflating a balloon in the distal oesophagus, 
causing the forced distension of the muscular fibers of the LES. Usually a balloon of 30 mm is used due 
to a lower perforation rate [17]. It’s possible to achieve similar long-term results to surgery with 
pneumatic dilatation if multiple dilatations are used. It seems to be a more effective treatment in patients 
over 40 years old [16, 18]. It is also the most cost effective procedure [4] and has a lower risk of 
gastroesophageal reflux disease [17].  Surgery is the gold-standard treatment and the most frequently used 
surgical procedure is Heller’s myotomy, performed laparoscopically (section of the muscular fibers of the 
LES). The laparoscopic approach results in shorter hospitalization times [19]. To prevent 
gastroesophageal reflux a partial fundoplicature must also be performed in conjunction with the myotomy 
[3, 16]. There seems to be no difference between the two different partial fundoplicatures, Dor or Toupet 
[20]. For the myotomy, most surgeons will perform a section of 6-8 cm of the LES fibres in the 
oesophagus and prolong it 1-2 cm into the stomach [21]. Surgery has great success rate in the long term 
[22], even though it is not completely free of complications and does not warrant the absence of relapse. 
Choosing between pneumatic dilatation or surgery has been a topic of recent discussion. A recent 
European RCT could not determine which approach was better, finding no statistical difference between 
them [17]. The symptom which shows greater improvement with surgery is regurgitation, in contrast with 
heartburn [20]. In general, post-surgical complications are scarce, with one studying relating incidence of 
complications in less than 4% of patients [23]. The most frequent adverse effect of the surgical 
intervention is gastroesophageal reflux. Another complication is the perforation of the oesophagus, 
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usually reported in around 5-10% of myotomies. A robotically assisted myotomy has been shown to 
lower the rate of perforation to 0% [24]. 
A new technique has been developed, known as POEM (per-oral endoscopy myotomy). In this technique 
the LES is sectioned through a tunnel created in the esophagus submucosa. [22]. The results using this 
technique have been promising, with significant decreases of the LES pressure [25]. One of the main 
criticisms of this approach is the lack of an anti-reflux procedure. In fact a study showed that around 46% 
patients had significative reflux just 6 months after the intervention [26]. 
The main goal of this study was to search for a relation between the parameters evaluated in the 
conventional manometry and the relapse of dysphagia post-operatively, the presence of post-operative 
heartburn and the usage of protein-pump inhibitors during follow-up. A secondary objective was to 
provide a report of the patients’ symptoms (pre-op and post-op) and characteristics’ and whether any of 
these factors could predict the development of post-operative dysphagia, heartburn and the usage of PPI 
drugs as well as the occurrence of intra-operative and post-operative morbidity. 
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METHODS 
Subjects and study protocol: We performed a retrospective observational study of all patients, 
admitted in the Upper Gastrointestinal Unit of Centro Hospitalar de São João, who underwent surgery for 
Achalasia, be it primary or relapse, between 1
st
 of January 2005 and 14
th
 May 2014.  The sample 
consisted of 46 patients, 25 female and 21 male. Patients younger than 18 years were excluded. To fulfil 
our aims, patient data was collected using the informatized systems of the hospital, and by consulting the 
manometry reports archived on paper.  Patient data was compiled in an electronic database.  
To evaluate the relation between manometric parameters and the post-operative symptoms, surgical 
complications, relapse of dysphagia and need for medical treatment, we reviewed all available 
manometric records, both pre-operatively and post-operatively. A sub-population of 20 patients, which 
had complete manometric data for both the pre-operative and post-operative periods, was created to 
evaluate the relation between pre-operative manometric parameters and post-operative outcomes.  
The variables used were: age at diagnosis; gender; diagnosis (primary achalasia or relapse); number of 
comorbidities; number of previous surgical procedures; pre-operative dilatations; type of surgery (heller-
dor or totalization of myotomy); approach (laparoscopy or laparotomy); intra-operative morbidity; 
hospitalization length; post-operative morbidity; proton pump inhibitors (PPI) treatment during follow-
up (starting in the first post-operative consultation or later) . Comorbidities were evaluated using 
Charlson Comorbidity Index [27] and morbidity was evaluated using the Clavien-Dindo Classification 
[28]. 
The symptoms recorded were: aspiration; siallorhea; halitosis; weight loss; chest Pain; bloating; 
heartburn; dysphagia; nocturnal cough; eructation; regurgitation; vomiting; nausea.  
Manometric variables evaluated were LES resting pressure; LES basal pressure; esophageal peristalsis; 
percentage of LES relaxation and LES functional length for both pre-operative and post-operative 
examinations.  
Ambulatory 24-hour Esophageal pH Monitoring: This examination was performed using a pH 
Orion II
®
 (single crystal antimony multi-use pH catheter ) catheter equipped with 2 electrodes. Catheters 
were introduced through transnasal approach and the sensors were placed at 15 cm and 5 cm from the 
GEJ (pH channel 1 and 2 respectively), whose location had been previously determined by manometry. 
We instructed patients to perform their regular routines, and to record their meal times, the time of sleep 
and whenever they experienced symptoms. After an average of 24 hours, patients returned to the hospital 
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to remove the sensors and check the information recorded. Data analysis using MMS
®
 software was 
performed, including the calculation of the DeMeester score.  
Manometry: Patients were submitted to the test in the supine position, after a fasting period of 12 
hours. The test was performed using a manometric tube with 8 sensors, 4 placed in the distal end and 4 
along the tube, 5 cm apart. This tube was inserted transnasally until the EGJ and then removed, cm by cm, 
by stationary pull-through so as to measure LES basal (normal: 10-25 mmHg) and residual pressures. 
LES relaxation was analysed using wet swallows of water (5mL). Relaxation was considered complete 
when LES pressure decreased to levels of gastric baseline pressure. Peristalsis was evaluated with a series 
of ten wet swallows. 
Surgical Procedure: The surgery was performed either by laparoscopy or laparotomy. The patient was 
placed in a modified lithotomy position. In the laparoscopic procedure the procedure began with the 
creation of a pneumoperitoneum. Afterwards five trocars were inserted. The liver was retracted. After the 
opening of the crura, the oesophagus was dissected into the mediastinum. Next the short gastric vessels 
were mobilized so as to facilitate the partial fundoplicature. The EGJ was identified and the myotomy was 
then performed using an L-shaped hook electrocautery device or an UltraCision ® device, cutting the 
longitudinal muscle fibers first. The circular muscle fibers were then exposed and sectioned. The 
myotomy was performed with a length of 6-8 cm in the esophagus and prolonged distally 1-2 cm to the 
stomach. After finishing the myotomy, a Dor fundoplicature was performed. As for the laparotomy 
approach, the procedure was similar, except that it was performed with a supraumbilical median incision.  
Statistical analysis: Statistical analysis was performed using IBM SPSS22 Statistics ®. Student t test 
was used to analyse independent samples when comparing two groups and the variables were 
quantitative. To assert whether a variable had a normal distribution or not, the Levene and the 
Kolmogorov-Smirnov tests were used. If normality could not be asserted, the proper non-parametric test 
(Mann-Whitney test) was used. When studying categorical variables, crosstabs were created and χ2-test 
or Fisher’s exact test were applied, according to the situation. To evaluate whether pre-operative factors 
affected the risk of post-operative outcomes, we performed logistic regression. Tests results were 
considered statistical significant for a level of p<0.05.  
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RESULTS 
A total of 46 patients were operated in our centre from 2005 to 2014. Mean age at diagnosis was 48.02 ± 
17.79 years old (range: 18-81 years old). 45.7% of patients were male and 54.3% were female. 40 patients 
had been diagnosed for the first time with Achalasia and 6 patients had relapse of the disease. Male 
patients had a lower age at diagnosis (46.10 years) when compared to female patients (49.64 years) 
without statistical difference (p=0.516). 
In our sample, 52.2% of patients had no comorbidities, 10.9% had 1, 17.4% had 2 comorbidities and 19.6 
had more than 2.  Applying the Charlson Comorbidity Index, 4 patients had grade I complications, 3 had 
grade II, 2 had grade III and only one had grade IV comorbidities. It’s also important to point out that one 
patient had multiple sclerosis and another had Down syndrome.  
The majority of the patients in our study had no prior surgical procedures (76.1%); 17.4% had 1; 4.3% 
had 2 surgical procedures and only 2.2% had been subjected to 3 surgeries before. 
In terms of pneumatic dilatations, 14 patients (30. 4%) had dilatations prior to surgery.  No information 
was found regarding the specific number of dilatations of 2 patients.  Mean number of dilatations was 
2.25 ± 1.288.  
In terms of the surgical technique used, 4 patients underwent myotomy totalization and the remaining 
patients were subjected to Heller-Dor surgery. No Toupet fundoplicature was performed. A 
cholecystectomy was performed in one patient in the same operative time, while 3 others underwent 
hiatal hernia correction in the same operative period.  
Most operations were performed laparoscopically, with only 10.9% of interventions performed through 
laparotomy. Only one patient was previously operated using the POEM technique. This patient relapsed 
and was operated laparoscopically, having complaints of heartburn and light dysphagia for solids after the 
surgery but no need for PPI treatment.  
The mean hospitalisation length was 6.10 days ± 10.67; the minimal period of stay was 2 days, while the 
maximum was 76 days (patient with Down syndrome, which developed nosocomial pneumonia and 
respiratory insufficiency). 
A complete report on all the patients’ symptoms and complaints pre-operatively and post-operatively, can 
be seen in table 1.Virtually all patients in the pre-operative period had dysphagia.  Information regarding 
the type of dysphagia was difficult to collect using the medical reports, with information about 22 patients 
missing. Despite that, the data available showed that 2.2% had dysphagia just for liquids, 8.7% had 
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isolated dysphagia for solids, 1 patient (2.2%) had paradoxal dysphagia and 18 patients had dysphagia for 
liquids and solids. In our sample, 21.8% of patients had dysphagia post-operatively. 5 patients had 
dysphagia for solids, 4 had dysphagia for liquids and solids and 1 had dysphagia for liquids only.  
No statistically significant associations were found between post-operative heartburn and pre-operative 
symptoms or patients’ characteristics (Table 2).  
A total of 23 patients performed a 24-hour pH-metry after the surgery. In our sample, 17.4% of patients 
had acid pathological reflux detected in the examination. Reflux was only detected in channel pH2, which 
was located at 5 cm from the GEJ. 75% of the patients who performed the examination showed no 
symptoms. 12.5% of patients had a negative symptom index while the remaining 12.5% had a positive 
symptom index. The association between post-operative complaints of heartburn and post-operative 
reflux demonstrated in 24-hour pH-metry was non-significant (p=0.281).  
No associations were found between pre-operative data and post-operative dysphagia, except for pre-
operative regurgitation and pre-operative heartburn (Table 2). Women had more dysphagia post-
operatively (40% vs 37.5) but there was no statistical difference (p=0.538). 
Patients who had pre-operative complaints of heartburn were less likely to have dysphagia post-
operatively (25% vs 75%, p<0.01). Pre-operative heartburn and age at diagnosis were not associated 
(p=0.254). Patients that had pre-operative regurgitation had less dysphagia when compared with patients 
who did not have regurgitation prior to the surgery (13.2% vs 45.2% respectively, p=0.034). In our study, 
patients who had pre-operative regurgitation had a higher age at diagnosis (56.53 vs 43.90; p= 0.024). 
The number of pre-operative co-morbidities was higher in patients with post-operative dysphagia (1.63 vs 
0.86) but this difference was not significant (p=0.074).  Patients who had post-operative dysphagia also 
had a higher age at diagnosis (50.94 vs 46.47 years old) but it wasn’t statistically significant (p=0334). 
In our population, 39.1% of patients started therapy with proton-pump inhibitors during follow-up. There 
were no differences between the patients who needed PPI treatment and those who didn’t when it comes 
to the number of comorbidities (p=0.449), age (p=0.350), the number of surgical procedures (p=0.683) 
and the number of dilatations (p=0.148). There was an association between the type of diagnosis (primary 
achalasia or relapse) and the need for PPI treatment in the post-operative period (32.5% vs 83.3% 
respectively, p= 0.028).   
No other statistically significant associations regarding post-operative PPI treatment were found (Table 
2).  
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There was no association between the patients who had pre-operative dilatations and post-operative 
heartburn (p=0.189), post-operative dysphagia (p=0.739), need for medical treatment (p=0.332) or reflux 
in the post-operative pH-metry (p= 0.273). 
The rate of intra-operative complications was 13%. Iatrogenic perforation of the oesophagus happened in 
4 patients, and 2 other had intra-operatory aspiration of vomit. One of these patients also suffered a spleen 
laceration. Regarding post-operative morbidity, 8.7% of patients had complications. Surgical wound 
dehiscence (Grade I of the Clavien-Dindo classification) was present in one patient, while another had 
surgical wound infection (Grade II). One patient experienced left superior member palsy (Grade I) and 
finally one had nosocomial pneumonia (Grade IV). There was no mortality in our sample, except for the 
patient with Down syndrome, who died due to complications of the disease.  
Concerning intra-operative morbidity, no predictors were found (Table 3). As for post-operative 
morbidity, patients who had a higher number of pre-operative dilatations had more morbidity after the 
surgery (p=0.035). 
We compared the manometric profile of patients before and after the surgery (Table 4). A significant 
decrease of LES basal and residual pressures was verified. Average LES functional length was 3.4 cm ±1 
cm. Before the surgery, 17 patients had positive intraoesophageal pressure and 7 had negative pressure.  
Post-operatively, only one patient had positive intraoesophageal pressure, while the remaining 24 had 
negative intraeosophageal resting pressure. The pre-operative and post-operatives manometric profiles did 
not differ with gender.  
We performed logistic regression to see if any pre-operative aspect of the patients’ manometric profile 
could have an impact in post-operative dysphagia, post-operative heartburn and the need for medical 
treatment. There were no statistically significant differences (Table 5). 
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DISCUSSION 
Achalasia has no curative treatment. All available treatments are palliative and have the main purpose of 
assuring the passage of liquids and solids through the gastroesophageal junction, therefore alleviating the 
symptomatology, preventing food stasis in the oesophagus and ultimately allowing the patient to eat. 
Furthermore, our knowledge of the disease, in pathophysiological terms, is still suboptimal. This leads to 
difficulty in identifying predictors of favourable outcomes for all treatments, including surgery. 
There have been previous reports regarding predictors of surgical success. One study reported that 
patients with a higher pre-operative score of dysphagia had better surgical outcomes [23], while other 
reported that a duration of symptoms longer than 10 years predicted more post-operative dysphagia [29]. 
This was also supported by Krishnamohan P et al., whose study also found that a sigmoid oesophagus 
shape in pre-operative tests was also a predictor of surgical success [30]. 
In this study we provide a complete report of the patients’ complaints, both pre-operatively and post-
operatively. The most commons symptoms before surgery, besides dysphagia, were heartburn and 
regurgitation. Heartburn remained the most common symptom even after surgery (34.8%). This is 
probably due to the fact that pre-operative and post-operative heartburn have different pathophysiological 
origins. This rate of heartburn is similar to other reports in the literature [31].  Despite this, only 17.4% of 
patients had had acid pathological reflux detected in the pH-metry post-operatively. This is in accordance 
to previous literature results [32] and can be explained by the low correlation between a patient 
complaining of heartburn and reflux and the demonstration of said reflux in the pH-metry. 
One of our main goals was to try and find which pre-operative characteristics could predict better 
outcomes after the surgery, namely less dysphagia, less reflux, less intra-operative and post-operative 
complications and a lower usage of PPI medication. 
Regarding post-operative dysphagia, we found two associations. First, patients which had pre-operative 
regurgitation had less post-operative dysphagia when compared with patients who did not have pre-
operative regurgitation (13.3% vs 45.2%, respectively, p=0.034). Interestingly, patients with pre-
operative regurgitation were older, at the time of diagnosis, than patients without regurgitation (56.53 vs 
43.90; p= 0.024). This was the only symptom which showed an association with age. It is a well-known 
fact that older patients, particularly over 60, have better outcomes after surgery, including less post-
operative dysphagia [33]. As such, we think that this predictor effect of regurgitation of a better outcome 
was due to the fact that, in our sample, patients who complained of said symptom were older. Secondly, 
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another interesting finding was that patients who had pre-operative complaints of heartburn were less 
likely to have dysphagia post-operatively (p<0.01). As in the case of regurgitation, patients who 
experienced pre-operative heartburn were older than patients who didn’t (51.04 years old vs 44.10 years 
old), even though it was not statistically significant (p=0.254). It’s possible that the explanation for this 
association is the same that we propose for the regurgitation and dysphagia association, and that our 
sample simply did not have the statistical power to demonstrate it. 
The type of diagnosis, the type of surgical approach, the number of co-morbidities did not prove to be 
predictors of post-operative dysphagia. Although women had more dysphagia post-operatively (40% vs 
37.5%) there was no significance (p=0.538).  Contrary to what has been reported about the patient’s age 
as a predictor of surgical outcomes [31], no association was found in our sample, even though patients 
who had post-operative dysphagia also had a higher age at diagnosis (50.94 vs 46.47 years old; p= 0.334).  
In terms of heartburn, we did not find any factors that could predict a higher incidence of this symptom 
post-operatively. This seems to be the case with other similar studies [29]. 39.1% of our patients started 
proton-pump inhibitor medication during follow-up. Although we could not find any predictors for post-
op heartburn, we did discover that the diagnosis can predict the need for PPI medication. Patients who 
had relapse of Achalasia were more likely to need PPI treatment (83.3% of patients with relapse needed 
PPI vs only 32.5% of patients with primary Achalasia; p= 0.028). No similar reports were found in the 
literature. A possible explanation may result from the fact that patients who relapse must endure a second 
myotomy, which further weakens the physiological anti-reflux mechanism, predisposing to more severe 
heartburn and a greater need for medication.  
LHM plus Dor fundoplicature proved to be an excellent treatment option for Achalasia. Our rate of post-
operative dysphagia rounded 21.8%, which is in accordance to the rates reported in the literature [4]. 
After the surgery there was a significant decrease in LES basal pressure (26.76 vs 6.41; p<0.01), as well 
as LES Residual pressure (13.10 vs 2,70, p<0.01). LES relaxation increased after the surgery (from 
55.54% to 67,54%) even though this was not a statistically significant increase ( p=0.134). Other studies 
have showed a non-significant increase as well [32].  
As for the pre-operative manometric parameters, we did not find any association between these 
characteristics and post-operative dysphagia, need for medical treatment and post-operative heartburn 
(Table 4).  
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We also evaluated intra-operative and post-operative morbidity. Our rate of complications, 13% and 7%, 
respectively, is within the normal range reported in previous works [23, 30, 31].  
When trying to assert possible predictors of morbidity, we found no factors that could predict intra-
operative morbidity. However, we did find an association between pre-operative pneumatic dilatations 
and post-operative morbidity (p=0.035). Dilatations are one of the most effective treatments available for 
Achalasia [4].  Nonetheless, one must take into account that previous dilatations can make the surgical 
technique more challenging and can perhaps lead to more complications for patients. Multiple reports in 
the literature have associated the existence of previous treatments and poorer surgical outcomes, this 
effect being greater with botulin toxin injection [5, 34, 35]. Smith et al. state that, in patients with 
previous dilatations, the submucosal dissection plane is obliterated [36]. Nevertheless, other articles found 
no association between pre-operative dilatations and surgical outcomes [29, 31].  
Taking this information into consideration, we think that pneumatic dilatations should be used carefully 
and that there should be a strict decision-making process on which patient does dilatation before surgery. 
One recent development that might help in this decision is the Chicago Classification, since it has been 
shown that patients with type II achalasia as defined by this classification respond better to any form of 
treatment and this subtype is a predictor of therapeutical success [10]. On the other hand, type I and type 
III of the Chicago Classification tend to predict a poorer outcome [5].  
The limitations of this study are the retrospective approach and the small sample size. Due to our sample 
size, a risk for a Type II error exists. Another limitation was the lack of complete data regarding the 
manometric reports of all patients.  
In conclusion, our study reinforces the efficacy of LHM as the current gold-standard of treatment for 
Achalasia while introducing the notion that there should be an extra care in terms of reflux for patients 
with relapse of the disease. It also shows that pneumatic dilatations, while curiously a safe option in terms 
of intra-operative morbidity, can lead to a higher incidence of post-operative morbidity and, as such, 
should be used with great care. It is our opinion that prospective studies with long follow-up are needed to 
uncover new predictors of surgery success or failure, specially taking into account the differences 
between subtypes of Achalasia elucidated by the new Chicago Classification. 
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ANNEX I- Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptom 
Pre-Operative Period Post-Operative Period 
Absolute 
Frequency 
Relative 
Frequency 
Absolute 
Frequency 
Relative 
Frequency 
Nausea 1 2,2% 5 10,9% 
Vomit 4 8,7% 5 10,9% 
Bloating/Fullness 2 4,3% 5 10.9% 
Regurgitation 15 32,6% 6 13% 
Heartburn 26 56,5% 16 34,8% 
Chest Pain 8 17,4% 1 2,2% 
Nocturnal Cough 3 6,5% 1 2,2% 
Aspiration 1 2,2% 0 0 
Sialorrhea 1 2,2% 1 2,2% 
Halitosis 2 4,3% 1 2,2% 
Weight Loss 9 19,6% 0 0 
Eructation 2 4,3% 1 2,2% 
Table 1: Patients’s symptons, pre-operative and post-operative 
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Pre-operative 
symptoms/Patient data 
N (%) Post-op Dysphagia 
Post-Op 
Heartburn 
Post-Op PPI Treatment 
Chest Pain 8 (17.4%) p=1 p=1 p=1 
Regurgitation 15 (32.6%) p=0,878 p=0,034 p=0,503 
Weight loss 9 (19.6%) p=1 p=0,7 p=1 
Nocturnal cough 3 (6.5%) p=0,542 p=1 p=0,270 
Heartburn 26 (56.5%) p=0,433 p<001 p=0,805 
Diagnosis (Primary or 
Relapse) 
 p=0,405 p=0,405 p=0,028 
Primary Achalasia 40 (87%)    
Relapse 6 (13%)    
Surgical approach  p=1 p=0,602 p=0,284 
Laparoscopic 41 (89.1%)    
Laparotomy 5 (10.9%)    
Intra-Operative 
Morbidity 
6 (13%) p=0,405 p=0,649 p=1 
Table 2: Associations between patient data and post-operative dysphagia, heartburn and PPI treatment 
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Patient Data Mean 
Intra-Operative 
Morbidity (p value) 
Post-Operative 
Morbidity (p value) 
Age 48.02 0.794 0.575 
Number of dilatations 0.61 0.898 0.035 
Number of surgeries 0.33 0.778 0,781 
Number of comorbidities 1.11 0.997 0,281 
Table 3: Predictors of intra-operative and post-operative morbidity 
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Manometric 
Parameters 
Pre-Operative Post-Operative 
P value 
Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
LES basal pressure 26,76 13,179 6,41 2,785 <0.01 
LES residual pressure 13,10 5,174 2,70 2,163 0,001 
LES relaxation (%) 55,54 13,617 67,54 20,602 0,134 
Table 4: Differences between manometric profiles, before and after surgery (LES: Lower esophageal sphincter) 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-operative Manometric 
parameters 
Post-operative Heartburn     (p 
value) 
Post-Operative Dysphagia   (p 
value) 
PPI Treatment 
(p value) 
LES basal pressure 
0.906 
0.421 0.395 
LES residual pressure 
0.728 
0.233 0.265 
LES relaxation pressure 
0.866 
0.471 0.387 
LES functional length 
0.326 
0.358 0.851 
Table 5: Manometric profile and the association with post-operative heartburn, dysphagia and PPI treatment (LES: Lower esophageal sphincter) 
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Figures in online appendices (Electronic supplementary Material) should, however, be numbered 
separately. 
Figure Captions: 
Each figure should have a concise caption describing accurately what the figure depicts. Include the 
captions in the text file of the manuscript, not in the figure file. Figure captions begin with the term 
Fig. in bold type, followed by the figure number, also in bold type. No punctuation is to be included 
after the number, nor is any punctuation to be placed at the end of the caption. Identify all elements 
found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs. 
Identify previously published material by giving the original source in the form of a reference citation 
at the end of the figure caption.  
Figure Placement and Size: 
When preparing your figures, size figures to fit in the column width. Figures should be 39 mm, 84 
mm, 129 mm, or 174 mm wide and not higher than 234 mm. The publisher reserves the right to 
reduce or enlarge figures. 
Permissions: 
If you include figures that have already been published elsewhere, you must obtain permission from 
the copyright owner(s) for both the print and online format. Please be aware that some publishers do 
not grant electronic rights for free and that Springer will not be able to refund any costs that may 
have occurred to receive these permissions. In such cases, material from other sources should be 
used.  
Accessibility: 
In order to give people of all abilities and disabilities access to the content of your figures, please 
make sure that all figures have descriptive captions (blind users could then use a texttospeech 
software or a texttoBraille hardware). Patterns are used instead or in addition to colors for conveying 
information (colorblind users would then be able to distinguish the visual elements) Any figure 
lettering has a contrast ratio of at least 4.5:1. 
ELECTRONIC SUPPLEMENTARY MATERIAL GUIDELINES 
Submission: 
Supply all supplementary material in standard file formats. To accommodate user downloads, please 
keep in mind that largersized files may require very long download times and that some users may 
experience other problems during downloading. 
Audio, Video, and Animations: 
Always use MPEG1 (.mpg) format. 
Text and Presentations: 
Submit your material in PDF format; .doc or .ppt files are not suitable for longterm viability. 
A collection of figures may also be combined in a PDF file. 
Spreadsheets: 
Spreadsheets should be converted to PDF if no interaction with the data is intended. 
If the readers should be encouraged to make their own calculations, spreadsheets should be 
submitted as .xls files (MS Excel). 
Collecting Multiple Files: 
It is possible to collect multiple files in a .zip or .gz file. 
Accessibility: 
In order to give people of all abilities and disabilities access to the content of your supplementary 
files, please make sure that the manuscript contains a descriptive caption for each supplementary 
material 
Video files do not contain anything that flashes more than three times per second (so that users 
prone to seizures caused by such effects are not put at risk) 
(Revised on January 20, 2015) 
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